Fox Rothschild IP Team Scores Major Victory in Biotech Patent Dispute

Apr 25, 2024 | News

A Fox Rothschild Intellectual Property team, including Wanda D. French-Brown, Howard Suh, Joe Chen, Michael W. Glynn, James H. McConnell and Luke Toft, successfully defended two biotechnology gene therapy patents on behalf of firm client San Rocco Therapeutics, LLC.

In October 2022, bluebird bio Inc. filed the inter partes review petitions, challenging claims of San Rocco’s exclusively licensed patents directed to recombinant vector systems expressing globin genes. San Rocco’s licensed patented technology covers lentiviral vectors used in gene therapy treatments for Sickle Cell Disease and Beta Thalassemia.

Suh and Chen presented oral arguments before the Patent Trial and Appeal Board in January 2024. The final decision, issued on April 22, found all the challenged claims of the two patents are not unpatentable.

View the rest of the article here

View the PDF

Contact us

Call Us

+1 (312) 441-1800

Our Locations

San Rocco Therapeutics
308 E. Emily St.
Tampa, FL 33603

 

Get in touch